Mike earned his PhD from Baylor College of Medicine where he focused on the intersection of progesterone and growth factor signalling and their role in endometrial receptivity. While finishing his work there, he was recruited by Mark Hughes of Genesis Genetics to open aResearch and Development PGS laboratory in Houston, Texas. Mike quickly rose to prominence as a technical expert and was instrumental in the adoption and implementation of Next Generation Sequencing in Genesis Genetics labs across the world.

Shortly after being acquired by CooperSurgical, he was promoted to Director of Genomic Laboratories, overseeing PGT-A testing for approximately 1,000 patients per month for two years. He was then promoted to his current role, leading research efforts in Genomics. His team recently lead and continues to develop state-of-the-art analytical methods for interrogating Reproductive Genetics.